Company registration number 15682837 (England and Wales)
DR J R KENNEDY SPORTS MEDICINE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
DR J R KENNEDY SPORTS MEDICINE LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
DR J R KENNEDY SPORTS MEDICINE LIMITED
BALANCE SHEET
AS AT
30 APRIL 2025
30 April 2025
- 1 -
2025
Notes
£
£
Fixed assets
Tangible assets
3
6,421
Current assets
Debtors
4
3,713
Cash at bank and in hand
8,920
12,633
Creditors: amounts falling due within one year
5
(6,025)
Net current assets
6,608
Total assets less current liabilities
13,029
Provisions for liabilities
(1,220)
Net assets
11,809
Capital and reserves
Called up share capital
100
Profit and loss reserves
11,709
Total equity
11,809

For the financial period ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 9 November 2025 and are signed on its behalf by:
Dr J R Kennedy
Director
Company registration number 15682837 (England and Wales)
DR J R KENNEDY SPORTS MEDICINE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 30 APRIL 2025
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Period ended 30 April 2025:
Profit and total comprehensive income
-
25,709
25,709
Issue of share capital
100
-
100
Dividends
-
(14,000)
(14,000)
Balance at 30 April 2025
100
11,709
11,809
DR J R KENNEDY SPORTS MEDICINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 APRIL 2025
- 3 -
1
Accounting policies
Company information

Dr J R Kennedy Sports Medicine Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Summit, Woodwater Park, Pynes Hill, Exeter, EX2 5WS.

1.1
Reporting period

These financial statements represent the period from incorporation on 26 April 2024 to the first reporting date of 30 April 2025 and therefore cover a period of more than a year. Due to this, future comparative amounts (including the related notes) may not be entirely comparable.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% Reducing Balance
Computers
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

DR J R KENNEDY SPORTS MEDICINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.8
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
Number
Total
2
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 26 April 2024
-
0
Additions
7,966
At 30 April 2025
7,966
Depreciation and impairment
At 26 April 2024
-
0
Depreciation charged in the period
1,545
At 30 April 2025
1,545
Carrying amount
At 30 April 2025
6,421
DR J R KENNEDY SPORTS MEDICINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 APRIL 2025
- 5 -
4
Debtors
2025
Amounts falling due within one year:
£
Trade debtors
2,860
Other debtors
853
3,713
5
Creditors: amounts falling due within one year
2025
£
Taxation and social security
4,824
Other creditors
1,201
6,025
6
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
2025
Balances:
£
Accelerated capital allowances
1,220
2025
Movements in the period:
£
Liability at 26 April 2024
-
Charge to profit or loss
1,220
Liability at 30 April 2025
1,220
7
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
£
Total commitments
32,163
DR J R KENNEDY SPORTS MEDICINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 APRIL 2025
- 6 -
8
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Advances
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
Two directors
-
-
15,260
(14,407)
853
-
15,260
(14,407)
853

The loan to the directors is unsecured and repayable on demand.

2025-04-302024-04-26falsefalsefalse21 November 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityDr J KennedyDr S Kennedy156828372024-04-262025-04-30156828372025-04-3015682837core:OtherPropertyPlantEquipment2025-04-3015682837core:CurrentFinancialInstrumentscore:WithinOneYear2025-04-3015682837core:WithinOneYear2025-04-3015682837core:CurrentFinancialInstruments2025-04-3015682837core:ShareCapital2025-04-3015682837core:RetainedEarningsAccumulatedLosses2025-04-3015682837bus:Director12024-04-262025-04-3015682837core:RetainedEarningsAccumulatedLosses2024-04-262025-04-3015682837core:ShareCapital2024-04-262025-04-3015682837core:FurnitureFittings2024-04-262025-04-3015682837core:ComputerEquipment2024-04-262025-04-3015682837core:OtherPropertyPlantEquipment2024-04-2515682837core:OtherPropertyPlantEquipment2024-04-262025-04-3015682837bus:PrivateLimitedCompanyLtd2024-04-262025-04-3015682837bus:SmallCompaniesRegimeForAccounts2024-04-262025-04-3015682837bus:FRS1022024-04-262025-04-3015682837bus:AuditExemptWithAccountantsReport2024-04-262025-04-3015682837bus:Director22024-04-262025-04-3015682837bus:FullAccounts2024-04-262025-04-30xbrli:purexbrli:sharesiso4217:GBP